Nucera, C. (2019). A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer. Oncotarget.
Citação norma ChicagoNucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.
MLA引文Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.
警告:這些引文格式不一定是100%准確.